Thomas W Loewald - Net Worth and Insider Trading

Thomas W Loewald Net Worth

The estimated net worth of Thomas W Loewald is at least $23 Million dollars as of 2024-04-20. Thomas W Loewald is the Senior Vice President of Thermo Fisher Scientific Inc and owns about 41,277 shares of Thermo Fisher Scientific Inc (TMO) stock worth over $22 Million. Thomas W Loewald is also the Director of Harvard Bioscience Inc and owns about 103,200 shares of Harvard Bioscience Inc (HBIO) stock worth over $380,808. Details can be seen in Thomas W Loewald's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Thomas W Loewald has not made any transactions after 2019-08-20 and currently still holds the listed stock(s).

Transaction Summary of Thomas W Loewald

To

Thomas W Loewald Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Thomas W Loewald owns 2 companies in total, including Harvard Bioscience Inc () , and Thermo Fisher Scientific Inc () .

Click here to see the complete history of Thomas W Loewald’s form 4 insider trades.

Insider Ownership Summary of Thomas W Loewald

Ticker Comapny Transaction Date Type of Owner
Harvard Bioscience Inc 2021-01-04 director
Thermo Fisher Scientific Inc 2017-04-27 Senior Vice President

Thomas W Loewald Latest Holdings Summary

Thomas W Loewald currently owns a total of 2 stocks. Among these stocks, Thomas W Loewald owns 41,277 shares of Thermo Fisher Scientific Inc (TMO) as of April 27, 2017, with a value of $22 Million and a weighting of 98.33%. Thomas W Loewald also owns 103,200 shares of Harvard Bioscience Inc (HBIO) as of August 20, 2019, with a value of $380,808 and a weighting of 1.67%.

Latest Holdings of Thomas W Loewald

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TMO Thermo Fisher Scientific Inc 2017-04-27 41,277 544.78 22,486,884
HBIO Harvard Bioscience Inc 2019-08-20 103,200 3.69 380,808

Holding Weightings of Thomas W Loewald


Thomas W Loewald Form 4 Trading Tracker

According to the SEC Form 4 filings, Thomas W Loewald has made a total of 0 transactions in Thermo Fisher Scientific Inc (TMO) over the past 5 years. The most-recent trade in Thermo Fisher Scientific Inc is the sale of 1,532 shares on April 27, 2017, which brought Thomas W Loewald around $258,540.

According to the SEC Form 4 filings, Thomas W Loewald has made a total of 1 transactions in Harvard Bioscience Inc (HBIO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Harvard Bioscience Inc is the acquisition of 20,000 shares on August 20, 2019, which cost Thomas W Loewald around $50,600.

Insider Trading History of Thomas W Loewald

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Thomas W Loewald Trading Performance

GuruFocus tracks the stock performance after each of Thomas W Loewald's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Thomas W Loewald is 20.4%. GuruFocus also compares Thomas W Loewald's trading performance to market benchmark return within the same time period. The performance of stocks bought by Thomas W Loewald within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Thomas W Loewald's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Thomas W Loewald

Average Return

43.86%

Average return per transaction

Outperforming Transactions

100%

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 38.8 20.4 5.6 43.86 78.18 9.14
Relative Return to S&P 500(%) 35.64 13.23 -10.7 27.19 54.47 -4.25

Thomas W Loewald Ownership Network

Ownership Network List of Thomas W Loewald

No Data

Ownership Network Relation of Thomas W Loewald


Thomas W Loewald Owned Company Details

What does Harvard Bioscience Inc do?

Who are the key executives at Harvard Bioscience Inc?

Thomas W Loewald is the director of Harvard Bioscience Inc. Other key executives at Harvard Bioscience Inc include director & Chief Executive Officer James W Green , Interim CFO Jennifer Cote , and Chief Financial Officer Michael A. Rossi .

Harvard Bioscience Inc () Insider Trades Summary

Over the past 18 months, Thomas W Loewald made no insider transaction in Harvard Bioscience Inc (). Other recent insider transactions involving Harvard Bioscience Inc () include a net purchase of 95,000 shares made by James W Green , and a net purchase of 30,000 shares made by Alan I Edrick .

In summary, during the past 3 months, insiders sold 0 shares of Harvard Bioscience Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Harvard Bioscience Inc () were sold and 125,000 shares were bought by its insiders, resulting in a net purchase of 125,000 shares.

Harvard Bioscience Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Harvard Bioscience Inc Insider Transactions

No Available Data

Thomas W Loewald Mailing Address

Above is the net worth, insider trading, and ownership report for Thomas W Loewald. You might contact Thomas W Loewald via mailing address: 81 Wyman Street, Waltham Ma 02451.

Discussions on Thomas W Loewald

No discussions yet.